Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Innovative and ultra-low power neuromorphic unit for advanced signal processing in wearable medical devices

Project description

New neuromorphic devices monitor chronic health problems in real time

Healthcare in Europe is becoming increasingly personalised, thanks to self-health monitoring. This is necessary with more than 50 million people suffering from chronic conditions. Present wearable devices with a self-monitoring system use specific microprocessors that consume high power and produce vast amounts of raw data requiring further complex analysis. The DynapIP project aims to resolve this using an ultra-low-power neuromorphic chip with extremely long battery life. Producing advanced signals in real time like the biological neuronal system, it is customisable with a large choice of biosensors (ECG, EOG, EMG and EEG). The chip will revolutionise diagnosis, making it immediate and easy.

Objective

Nowadays, ~220M of the worldwide population of which over 50M only in EU, currently live with more than one chronic condition. Early and accurate detection of adverse events are fundamental for proper clinical management. To meet this need, the healthcare system is becoming increasingly personalized with the help of self-health monitoring systems and in particular medical wearable devices. However, constant monitoring generates large amounts of raw data which must be stored and processed to extract pathological biomarkers. Normally, this is done using microprocessors commonly found in computers as central processing units (CPUs) or graphic processing units (GPUs), or on specialized microprocessors such as digital signal processors (DSPs) that have some limitations as implying high power consumption (>100W) and no real time signal processing.
aiCTX offers DynapIP, a neuromorphic chip with extremely long battery life (3 months) and low-power consumption (<100uW) able to perform sophisticated signal processing and react to sensory input in real-time enabling continuous monitoring and real time analysis of biological signals captured by wearable medical devices. The hardware can be fully customized based on client needs and these approaches can be applied to a wide variety of biosensors, such as ECG, EOG, EMG and EEG. Wearable devices using DynapIP automatically identify in real-time (less than 100ms) pathological events with high accuracy facilitating faster and immediate diagnosis for healthcare personnel.
During the feasibility assessment, a go-to-market strategy will be established, as well as further development plan will be drafted. During the innovation project, aiCTX will optimize the existing neuron/synapses hardware modules for different biosensors and the software integration to support the new hardware modules of the DynapIP. Pilot study for validation of biosignal analysis and functionality of the technology will be conducted together with secured partners

Programme(s)

Topic(s)

Funding Scheme

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

SYNSENSE AG
Net EU contribution
€ 50 000,00
Address
THURGAUERSTRASSE 60
8050 ZURICH
Switzerland
SME
Yes
Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00